PIKFYVE expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 6.89549994881133E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.575820E-04 |
Normal-vs-Stage2 |
1.019270E-03 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.573920E-02 |
Stage1-vs-Stage2 |
9.991800E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
4.628800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
3.570200E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.0146000001553E-07 |
Normal-vs-AfricanAmerican |
6.24170004570601E-09 |
Normal-vs-Asian |
7.526300E-02 |
Caucasian-vs-AfricanAmerican |
4.996300E-03 |
Caucasian-vs-Asian |
4.784200E-01 |
AfricanAmerican-vs-Asian |
6.657900E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
6.245600E-04 |
Normal-vs-Female |
3.82119999997599E-06 |
Male-vs-Female |
2.524800E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.411820E-02 |
Normal-vs-Extreme_Weight |
2.036800E-04 |
Normal-vs-Obese |
6.544000E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.854200E-01 |
Normal_Weight-vs-Obese |
7.602400E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
4.983000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.05919999998849E-06 |
Normal-vs-Age(41-60Yrs) |
8.561900E-03 |
Normal-vs-Age(61-80Yrs) |
2.54079999995049E-06 |
Normal-vs-Age(81-100Yrs) |
3.311600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.217200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.094600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.168600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.649600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.112800E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.765600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
5.643000E-01 |
Normal-vs-Grade 3 |
3.680400E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
6.946200E-01 |
Grade 2-vs-Grade 4 |
5.643000E-01 |
Grade 3-vs-Grade 4 |
3.680400E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.87849999999656E-06 |
Normal-vs-N1 |
9.202700E-03 |
N0-vs-N1 |
9.755200E-01 |
|
|